Time for Faken and Cdngreentrader to help us speculate in some Canadian penny stocks. Got any?
?

Nov 15th, 2021 1:36 am
Nov 15th, 2021 1:37 am
Nov 15th, 2021 8:39 am
Nov 15th, 2021 9:15 am
What did you expect? I'm thinking of rebuying some shares.
Nov 15th, 2021 9:23 am
Nov 15th, 2021 10:05 am
Nov 15th, 2021 10:11 am
Thats due to people who were hoping for the uplisting and bitgo purchase to be announced today, so they are bailing, but long term, very positive morning.tietherope wrote: ↑ So that's why it's red lol
Nov 15th, 2021 10:20 am
Nov 15th, 2021 10:24 am
Traders looking for a quick buck and selling off.
Nov 15th, 2021 10:45 am
Nov 15th, 2021 10:49 am
Nov 15th, 2021 10:57 am
Nov 15th, 2021 10:59 am
Go look at the financials and the past ERs. You'll understand why I'm bullish on this now. Look into the Pulsevet financials to. Pretty much big upside on this.
Nov 15th, 2021 11:21 am
Nov 15th, 2021 11:30 am
Stonks, unfortunately, don't only go up. If the penny stock goes down, not only will you lose out on the TFSA room when you sell, but you'll also not be able to claim the losses against your income. And many penny stocks are penny stocks for very good reasons, and its price can fluctuate and shift on a dime.MtX wrote: ↑ If you're making money wouldn't you want to pay less taxes? As long as you're not using your TFSA to exclusively day trade, why should you get audited? Why can't we buy a penny stock like VSBY in our TFSA and set aside half for swing trading and the other half for long term trading (price target $10)?
Nov 15th, 2021 11:44 am
Nov 15th, 2021 12:00 pm
Nov 15th, 2021 12:09 pm
Yes this is all correct. Revenue is not what you should be focusing on right now. It's future potential growth. They were giving away units to veterinarians. Increased from 44 to 144 last quarter. Pulsevet revenue not included in this report. I think they make around 6-25million per quarter. They are self sufficient so no extra man power needed to fund them. Their net cash will go down for next er because of this purchase. Expenses will be paid for my revenue from pulsevet. What I need to see now is how well the new CEO sells the cartridges (this is how they make money right now)..JetLi wrote: ↑ Is this the biggest point? I read through it, the revenue vs 2020 didn't seem positive to me, the R&D reduction seemed good, but this was the point that stood out to me.
Zomedica had cash and cash equivalents of approximately $271.4 million as of September 30, 2021, compared to approximately $52 as of September 30, 2020 and "Net cash from financing activities for the nine months ended September 30, 2021 was approximately $219.1 million, compared to approximately $64.1 million for the nine months ended September 30, 2020, an increase of approximately $155.1 million, or 242%. "
I have been trying to read and understand these, but I'm still new to reading them.
Nov 15th, 2021 12:19 pm
early 2021 on the financing deal added approx 100 million shares - the stock has dropped since that happened.JetLi wrote: ↑ Zomedica had cash and cash equivalents of approximately $271.4 million as of September 30, 2021, compared to approximately $52 as of September 30, 2020 and "Net cash from financing activities for the nine months ended September 30, 2021 was approximately $219.1 million, compared to approximately $64.1 million for the nine months ended September 30, 2020, an increase of approximately $155.1 million, or 242%.
Nov 15th, 2021 12:42 pm
There are currently 2 users viewing this thread. (0 members and 2 guests)